ArticlePharmaceuticals (Basel, Switzerland)2022

A SERPINE1-Based Immune Gene Signature Predicts Prognosis and Immunotherapy Response in Gastric Cancer.

Xiang Xu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.